Including Both Costs and Effects – The Challenge of Using Cost-Effectiveness Data in National-Level Policy-Making: A Response to Recent Commentaries

oleh: Nathalie Eckard, Magnus Janzon, Lars-Åke Levin

Format: Article
Diterbitkan: Kerman University of Medical Sciences 2015-08-01

Deskripsi

Incorporating cost-effectiveness data in the priority-setting decisions is a distinguishing feature in the Swedish national guidelines. This differentiates the Swedish guidelines from its European and American counterparts. The broader perspective is aimed at facilitating explicit resource allocations and priority-setting in healthcare, all in accordance with the three guiding ethical principles stated in the Health and Medical Services Act.1 The guidelines consist of recommendations in the form of a priority-setting decisions produced by a Priority-Setting Group (PSG) and the work process involves appraising the evidence used as decision support (including cost-effectiveness).